z-logo
open-access-imgOpen Access
Pharmacokinetics of ascending doses of ivermectin in Trichuris trichiura-infected children aged 2–12 years
Author(s) -
Jessica D. Schulz,
Jean T. Coulibaly,
Christian Schindler,
David Wimmersberger,
Jennifer Keiser
Publication year - 2019
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkz083
Subject(s) - ivermectin , pharmacokinetics , medicine , cmax , trichuris trichiura , gastroenterology , area under the curve , anthelmintic , immunology , veterinary medicine , helminths , ascaris lumbricoides
Yearly, millions of children are treated globally with ivermectin mainly for neglected tropical diseases. Anatomical, physiological and biochemical differences between children and adults may result in changes in pharmacokinetics. However, paediatric pharmacokinetic data of ivermectin are lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom